Heart Failure and Coronavirus Disease-19

Refli Hasan

doi:10.3889/oamjms.2021.6124

Authors

Refli Hasan Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6124

Keywords:

Coronavirus disease-2019, Heart failure, Management, Telemedicine

Abstract

Globally, 4.2% population suffer from heart failure. The condition has a mortality rate between 56% and 78%. Coronavirus disease-2019 (COVID-19) was first reported in December 2019 and became a pandemic since March 11, 2020. As COVID-19 emerges, cardiovascular disorders including, heart failure, become one of the most common comorbidity that increase the risk for contracting the disease. Heart failure and COVID-19 have reciprocal relationship. Patients with heart failure are at higher risk for COVID-19 with more unfavorable outcome. COVID-19 itself may deteriorate pre-existing heart failure in the subject. This situation is mediated by the presence of angiotensin converting enzyme-2 (ACE-2) in cardiac myocytes and pericytes, direct effect of viral invasion to myocytes and pericytes, downregulation of ACE-2 which hampers cardiovascular function, and uncontrolled inflammation known as cytokine storm. Prudent management, including implementation of telemedicine, continuation of ACE inhibitor and angiotensin receptor blocker, and medications’ side effects monitoring, is important in managing patients with coexisting heart failure and COVID-19.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. https://doi.org/10.1002/ejhf.1858 PMid:32483830 DOI: https://doi.org/10.1002/ejhf.1858

Callender T, Woodward M, Roth G, Farzadfar F, Lemarie J, Gicquel S, et al. Heart failure care in low-and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2014;11(8):e1001699. https://doi.org/10.1371/journal.pmed.1001699 PMid:25117081 DOI: https://doi.org/10.1371/journal.pmed.1001699

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi- Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-71. https://doi.org/10.1016/j.jacc.2020.03.031 PMid:32201335 DOI: https://doi.org/10.1016/j.jacc.2020.03.031

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-9. https://doi.org/10.1007/s10096-020-03874-z PMid:32291542 DOI: https://doi.org/10.1007/s10096-020-03874-z

World Health Organization. Coronavirus Disease (COVID-19) Outbreak Situation. Geneva: World Health Organization; 2021. Available from: http://www.covid19.who.int. [Last accessed on 2021 Apr 01].

Geng Y, Wei Z, Qian H, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107228. https://doi.org/10.1016/j.carpath.2020.107228 PMid:32375085 DOI: https://doi.org/10.1016/j.carpath.2020.107228

Ruslie RH, Darmadi D. Coronavirus disease-19 and mental health. Open Access Maced J Med Sci. 2020;8(1):268-71. https://doi.org/10.3889/oamjms.2020.5304 DOI: https://doi.org/10.3889/oamjms.2020.5304

Siregar GA, Siregar GP, Darmadi D, Ruslie RH. Coronavirus disease-19 and liver injury. Open Access Maced J Med Sci. 2020;8:154-7. https://doi.org/10.3889/oamjms.2020.5028 DOI: https://doi.org/10.3889/oamjms.2020.5028

Siregar GA, Siregar GP, Darmadi D. Gastrointestinal aspects of COVID-19: A review. Open Access Maced J Med Sci. 2020;8:52-4. https://doi.org/10.3889/oamjms.2020.4891 DOI: https://doi.org/10.3889/oamjms.2020.4891

Ruslie RH, Darmadi D, Siregar GA. Pediatric immunization practice during coronavirus disease-2019 pandemic. Open Access Maced J Med Sci. 2020;8:258-60. https://doi.org/10.3889/oamjms.2020.5125 DOI: https://doi.org/10.3889/oamjms.2020.5125

Ruslie RH, Darmadi D, Siregar GA. Susceptibility of coronavirus disease-19 in pediatric population. Open Access Maced J Med Sci. 2020;8:363-5. https://doi.org/10.3889/oamjms.2020.5240 DOI: https://doi.org/10.3889/oamjms.2020.5240

de Vries AA. SARS-CoV-2/COVID-19: A primer for cardiologists. Neth Heart J. 2020;28(7-8):366-83. https://doi.org/10.1007/s12471-020-01475-1 PMid:32671650 DOI: https://doi.org/10.1007/s12471-020-01475-1

Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, et al. Telemedicine in heart failure during COVID-19: A step into the future. Front Cardiovasc Med. 2020;7:612818. https://doi.org/10.3389/fcvm.2020.612818 PMid:33363223 DOI: https://doi.org/10.3389/fcvm.2020.612818

Dalia T, Lahan S, Ranka S, Acharya P, Gautam A, Goyal A, et al. Impact on congestive heart failure and role of cardiac biomarkers in COVID-19 patients. A systematic review and meta-analysis. Indian Heart J. 2021;73(1):91-8. https://doi.org/10.1016/j.ihj.2020.12.002 PMid:33714416 DOI: https://doi.org/10.1016/j.ihj.2020.12.002

Bader F, Mania Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev. 2021;26(1):1-10. https://doi.org/10.1007/s10741-020-10008-2 PMid:32720082 DOI: https://doi.org/10.1007/s10741-020-10008-2

Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, et al. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol. 2020;61(6):381-95. https://doi.org/10.1016/j.hjc.2020.05.004 PMid:32534109 DOI: https://doi.org/10.1016/j.hjc.2020.05.004

Shafi AM, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-a systematic review. J Card Surg. 2020;35(8):1988-2008. https://doi.org/10.1111/jocs.14808 PMid:32652713 DOI: https://doi.org/10.1111/jocs.14808

Oz M, Lorke DE, Kabbani N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacol Ther. 2020;221:107750. https://doi.org/10.1016/j.pharmthera.2020.107750 PMid:33275999 DOI: https://doi.org/10.1016/j.pharmthera.2020.107750

Savarese G, Benson L, Sundstrom J, Lund LH. Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: A 1.4 million patient nationwide registry analysis. Eur J Heart Fail. 2020;23(3):476-85. https://doi.org/10.1002/ejhf.2060 PMid:33222412 DOI: https://doi.org/10.1002/ejhf.2060

Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham heart study and the epidemiology of cardiovascular diseases: A historical perspective. Lancet. 2014;383(9921):999-1008. https://doi.org/10.1016/s0140-6736(13)61752-3 PMid:24084292 DOI: https://doi.org/10.1016/S0140-6736(13)61752-3

Fosbol EL, Butt JH, Ostergaard L, Andersson C, Selmer C, Kragholm K, et al. Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA. 2020;324(2):168-77. https://doi.org/10.1001/jama.2020.11301 PMid:32558877 DOI: https://doi.org/10.1001/jama.2020.11301

Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GY. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Med. 2020;17(9):e1003321. https://doi.org/10.1371/journal.pmed.1003321 PMid:32911500 DOI: https://doi.org/10.1371/journal.pmed.1003321

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi.org/10.1016/s0140-6736(20)30566-3 PMid:32171076 DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

Gorodeski EZ, Goyal P, Cox ZL, Thibodeau JT, Reay RE, Rasmusson K, et al. Virtual visits for care of patients with heart failure in the era of COVID-19: A statement from the heart failure society of America. J Card Fail. 2020;26(6):448-56. https://doi.org/10.1016/j.cardfail.2020.04.008 PMid:32315732 DOI: https://doi.org/10.1016/j.cardfail.2020.04.008